White Paper: Investment in Supply Chain Visibility Saves Costs

A risk-based approach to monitoring investigational medicinal products can help pharmaceutical companies improve supply chain efficiency, but to do this without compromising quality relies fast access to comprehensive shipment data. Using the cloud temperature monitoring solution and data loggers from TSS, GlaxoSmithKline has saved £4 million annually.

A risk-based approach to monitoring investigational medicinal products can help pharmaceutical companies improve supply chain efficiency, but to do this without compromising quality relies fast access to comprehensive shipment data. Using the cloud temperature monitoring solution and data loggers from TSS, GlaxoSmithKline has saved £4 million annually.

Investment in Supply Chain Visibility Saves Costs

Download this article where Clinical Trials Insight hears from Rob Montague, Director of Supply Chain Logistics – IMP at GSK; and Niclas Ohlsson, CEO of TSS, about how investment in supply chain visibility saves enormous costs.